Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer

PURPOSE: The purpose of this study was to observe the clinical efficacy and toxicity of cisplatin in combination with gemcitabine or Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS: A total of 200 patients with advanced NSCLC, which was c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ai, Dan, Guan, Yan, Liu, Xiu-Ju, Zhang, Chu-Feng, Wang, Peng, Liang, Hong-Lu, Guo, Qi-Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033500/
https://www.ncbi.nlm.nih.gov/pubmed/27695347
http://dx.doi.org/10.2147/OTT.S109683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033500/
https://www.ncbi.nlm.nih.gov/pubmed/27695347
http://dx.doi.org/10.2147/OTT.S109683

Ejemplares similares